Manufacturing cannabis is difficult enough. Manufacturing Medicinal GMP Cannabis is working a whole different level. It is bringing the industry standard to the level of pharmaceutical grade cannabis. Although this press release was in June, it went largely unrecognized despite its significance.
Medicinal GMP Cannabis under ICH GMP Guidelines.
First of all, the International Council on Harmonization of Technical Requirements for Pharmaceuticals for Human Use is the globalized standards for manufacturing Active Pharmaceutical Ingredients (APIs). This is the same level of care applied to any pharmaceutical that you might consume.
MedReleaf leading the way on GMP Cannabis.
ICH Guidelines are particularly relevant for GMP Cannabis Manufacturing, because ICH recognizes that some APIs are derived from botanical substances. This is the case for a company like MedReleaf, that is manufacturing GMP Cannabis flowers and consumable products to the specifications of Health Canada Good Production Practices (GPPs). However, MedReleaf is applying ICH principles, suggesting that they are treating all aspects of their manufacturing to the ICH GMP guidelines.
Check out their press release here:
Significance of manufacturing GMP Cannabis under ICH GMP Guidelines.
This is a very important step towards the legitimization of Medicinal GMP Cannabis Manufacturing, and the ability to export into international markets. Right now, Canada is poised to be the world supplier of GMP Cannabis, that meets the strict requirements of countries like Chile, Germany, and Australia, to name a few.
Orion GMP Solutions is a Pharmaceutical Process Engineering firm based out of Detroit Michigan. We specialize in the implementation and auditing of GMP Cannabis Manufacturers to assist them in reaching international markets. If you would like to get more information, please send us an email at email@example.com.
This content was written and supported by Orion GMP Solutions.